EMBC Embecta Corp.
Healthcare$3.32+0.00%ClosedMarket Cap: $197.0M
As of 2026-05-26
Valuation
P/E (TTM)
3.76
PEG
0.03
P/B
-0.31
P/S
0.19
EV/EBITDA
4.11
DCF Value
$39.73
FCF Yield
103.9%
Div Yield
18.1%
Margins & Returns
Gross Margin
62.5%
Operating Margin
29.8%
Net Margin
10.7%
ROE
-17.5%
ROA
10.9%
ROIC
25.8%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q2 null | $221.8M | 56.4% | $42.9M | $-4.1M | $— | $0.15 |
| Q1 null | $261.2M | 67.2% | $97.1M | $44.1M | $— | $0.15 |
| Q4 null | $264.0M | 59.1% | $64.4M | $26.4M | $— | $0.15 |
| FY null | $1.08B | 62.9% | $329.3M | $95.4M | $— | $0.60 |
| Q3 null | $295.5M | 66.0% | $106.1M | $45.5M | $— | $0.15 |
| Q2 null | $259.0M | 62.4% | $78.5M | $23.5M | $— | $0.15 |
| Q1 null | $261.9M | 63.7% | $76.9M | $-700.0K | $— | $0.15 |
| Q4 null | $286.1M | 59.9% | $33.6M | $14.6M | $— | $0.15 |
| FY null | $1.12B | 64.9% | $174.2M | $78.3M | $— | $0.60 |
| Q3 null | $272.5M | 69.0% | $55.9M | $14.7M | $— | $0.15 |
| Q2 null | $287.2M | 64.1% | $39.2M | $28.9M | $— | $0.15 |
| Q1 2024 | $277.3M | 67.0% | $47.4M | $20.1M | $0.35 | $0.15 |